logo

Morphosys Ag (MOR)



Trade MOR now with
  Date
  Headline
5/14/2020 9:34:56 AM MorphoSys, Incyte Report Updated Results From Ongoing Phase 2 L-MIND Study
5/6/2020 4:43:21 PM MorphoSys Q1 Basic EPS EUR 6.12 Vs Loss EUR 0.72 Last Year
4/27/2020 5:30:16 PM MorphoSys And I-Mab: First Patient Dosed In Phase 3 Clinical Trial of MOR202/TJ202 In R/r Multiple Myeloma In China
4/21/2020 4:21:22 PM MorphoSys Appoints Roland Wandeler Chief Commercial Officer
3/18/2020 11:12:15 PM MorphoSys FY19 Loss Widens
3/2/2020 1:04:39 AM MorphoSys: FDA Accepts Filing Of BLA, Granted Priority Review For Tafasitamab
2/4/2020 4:04:01 PM MorphoSys Initiates Expanded Access Program In U.S. For Tafasitamab
1/13/2020 1:38:40 AM MorphoSys Enters Global Collaboration And Licensing Agreement With Incyte
12/30/2019 8:22:20 AM MorphoSys Announces Submission Of BLA For Tafasitamab In R/r DLBCL To FDA
11/6/2019 4:24:46 PM MorphoSys To Present Number Of Important Updates On Tafasitamab At ASH